OBJECTIVES: CD44 comprises a family of isoforms involved in tumorigenesis,
Here we investigate the role of CD44 isoforms in head and neck squamous cel
l carcinoma (HNSCC) progression.
MATERIALS AND METHODS: HNSCC specimens underwent reverse transcriptase-poly
merase chain reaction (RT-PCR) followed by Southern blot analysis. After su
rface biotinylation, FaDu (hypopharyngeal HNSCC) and CD44v3-transfected COS
-7 cells were CD44 antibody-precipitated and compared by Western blot analy
sis. FaDu cells underwent double immunofluorescence staining and growth ass
ays.
RESULTS: Southern blot analysis suggested differential CD44v3 isoform expre
ssion in tumor and normal tissue. Cloning and sequencing revealed 2 novel C
D44v isoforms, Western blot analysis suggested CD44v3 expression in COS-7 t
ransfectants and FaDu, Double immunofluorescence staining revealed colocali
zation of CD44v3 and actin in FaDu projections, Anti-CD44v3 antibody decrea
sed FaDu growth.
CONCLUSION: HNSCC tissue and FaDu appear to express CD44v3 isoforms, These
isoforms may promote tumorigenesis.
CLINICAL SIGNIFICANCE: CD44v3 isoforms may be effective tumor markers and t
argets for HNSCC therapy.